WHO Solidarity trial: Remdesivir has no substantial effect on mortality in COVID-19 patients

WHO Solidarity trial: Remdesivir has no substantial effect on mortality in COVID-19 patients

WHO's Solidarity trial find Remdesivir, along with hydroxychloroquine, lopinavir/ritonavir and interferon, to have little or no effect on 28-day COVID-19 mortality.

6 days ago

WHO To Issue Guidelines On Emergency Use Of Remdesivir Following Randomised Control Trial

WHO To Issue Guidelines On Emergency Use Of Remdesivir Following Randomised Control Trial

WHO has said that the interim results from a clinical trial which it coordinated show that Remdesivir has little or no effect in preventing death from COVID-19.

7 days ago

Gilead's Remdesivir Ineffective In COVID-19 Patients, WHO Study Finds

Gilead's Remdesivir Ineffective In COVID-19 Patients, WHO Study Finds

Gilead Sciences, Inc.'s (NASDAQ: GILD) antiviral drug remdesivir has been found to have "little or no effect on mortality on hospitalized COVID-19," a global study conducted by the World Health Organization has concluded. The study is posted on a pre-print ...

7 days ago

Drug firm Gilead is outraged after finding from WHO remdesivir trial

Drug firm Gilead is outraged after finding from WHO remdesivir trial

Gilead Sciences says the findings appear inconsistent with evidence from other studies validating the clinical benefit of remdesivir.

7 days ago

WHO study finds remdesivir didn't help COVID-19 patients

WHO study finds remdesivir didn't help COVID-19 patients

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier.

7 days ago

WHO to soon issue guidelines on use of emergency drug Remdesivir

WHO to soon issue guidelines on use of emergency drug Remdesivir

The World Health Organization is set to issue policy guidelines in several weeks on the use of the antiviral drug Remdesivir, which has been given in emergency use to treat COVID-19 in several countries.

7 days ago

WHO to soon issue guidelines on use of emergency drug Remdesivir

WHO to soon issue guidelines on use of emergency drug Remdesivir

Geneva [Switzerland], October 17 (ANI): The World Health Organization is set to issue policy guidelines in several weeks on the use of the antiviral drug Remdesivir, which has been given in emergency use to treat COVID-19 in several countries.

7 days ago

Just One Drug–Dexamethasone–Effective Treatment For Covid-19, Says WHO Chief.

Just One Drug–Dexamethasone–Effective Treatment For Covid-19, Says WHO Chief.

“For the moment, the corticosteroid dexamethasone is still the only therapeutic shown to be effective against COVID-19, for patients with severe disease,” Tedros said this week. Currently, the drug dexamethasone is still the only therapeutic shown to be ...

7 days ago

WHO to soon issue guidelines on use of emergency drug Remdesivir

WHO to soon issue guidelines on use of emergency drug Remdesivir

Geneva [Switzerland], October 17 (ANI): The World Health Organization is set to issue policy guidelines in several weeks on the use of the antiviral drug Remdesivir, which has been given in emergency use to treat COVID-19 in several countries. "The WHO ...

7 days ago

Remdesivir fails to prevent Covid-19 deaths in massive trial

Remdesivir fails to prevent Covid-19 deaths in massive trial

Remdesivir fails to prevent Covid-19 deaths in massive trial. Remdesivir, the only antiviral drug sanctioned by the US Food and Drink Administration (FDA)

7 days ago

WHO: Remdesivir, Hydroxychloroquine have little or no effect on severe COVID-19 cases

WHO: Remdesivir, Hydroxychloroquine have little or no effect on severe COVID-19 cases

WHO announced that a sixth-month randomized trial of COVID-19 treatments found “conclusive evidence” that remdesivir has little or no effect on severe cases.

7 days ago

WHO-backed study finds no remdesivir benefit for hospitalized COVID-19 patients

WHO-backed study finds no remdesivir benefit for hospitalized COVID-19 patients

A multicountry study funded by the World Health Organization found that the antiviral drug remdesivir didn't reduce deaths from Covid-19 in hospitalized patients.

7 days ago

Associated Press: WHO study finds remdesivir didn't help COVID-19 patients

Associated Press: WHO study finds remdesivir didn't help COVID-19 patients

(FILES) In this file photo taken on April 8, 2020 one vial of the drug Remdesivir lies during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, ...

7 days ago

US touted COVID-19 cure, Remdesivir, fails WHO trials as US confirmed cases surge past 8m

US touted COVID-19 cure, Remdesivir, fails WHO trials as US confirmed cases surge past 8m

A World Health Organization study confirms Remdesivir, Trump administration's much-touted COVID-19 treatment, is not a miracle cure according to its trials involving more than 10000 patients. Experts worry misleading and ineffective measures in the US are ...

7 days ago

COVID-19: Remdesivir Caught in Storm After Poor WHO Trial Results and EU Deal

COVID-19: Remdesivir Caught in Storm After Poor WHO Trial Results and EU Deal

A lab technician holds a box of remdesivir tablets in Cairo, Egypt, June 25, 2020. Photo: REUTERS/Amr Abdallah Dalsh. New Delhi: The European Union should renegotiate a 1 billion euro ($1.2 billion) contract it sealed last week with Gilead for a six-month ...

7 days ago

Dexamethasone, only therapeutic effective against Covid-19, WHO chief states

Dexamethasone, only therapeutic effective against Covid-19, WHO chief states

Currently, the drug dexamethasone is still the only therapeutic shown to be effective against the novel coronavirus for severe patients, the chief of the World Health Organization said Friday.

7 days ago

WHO names the only therapeutic shown to be effective against Covid-19

WHO names the only therapeutic shown to be effective against Covid-19

Corticosteroid dexamethasone, unlike remdesivir and interferon, indeed has a positive effect on patients with severe disease. Ukranews. The World Health Organization considers dexamethasone to be the only effective drug in Covid-19 treatment. This was ...

7 days ago

WHO study finds remdesivir didn't help COVID-19 patients

WHO study finds remdesivir didn't help COVID-19 patients

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries.

7 days ago

Remdesivir has little effect on hospital stay or mortality in COVID-19 patients, WHO study finds

Remdesivir has little effect on hospital stay or mortality in COVID-19 patients, WHO study finds

Gilead Sciences Inc.'s remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization has found.

7 days ago

World Health Organization says remdesivir does not help coronavirus patients

World Health Organization says remdesivir does not help coronavirus patients

A large study led by the World Health Organization suggests the antiviral drug remdesivir did not help hospitalised COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries.

7 days ago

Remdesivir not effective: Study

Remdesivir not effective: Study

New Delhi, October 16 Widely prescribed anti-viral drug Remdesivir has shown no benefit in reducing Covid-19 deaths, the world's largest trial on the efficacy of four repurposed drugs has revea.

7 days ago

WHO study finds remdesivir didn't help COVID-19 patients

WHO study finds remdesivir didn't help COVID-19 patients

GENEVA (AP) -- A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patie.

7 days ago

Who study finds Remdesivir has little to no effect on COVID

Who study finds Remdesivir has little to no effect on COVID

The World Health Organisation (WHO) on Friday said that the world's largest randomised trial of COVID-19 treatments found “conclusive evidence” that Remdesivir, a drug used to treat US President Donald Trump.

7 days ago

Remdesivir useless in covid fight: WHO

Remdesivir useless in covid fight: WHO

A World Health Organization (WHO) trial of Gilead Sciences Inc.'s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the ...

7 days ago

Sales of first big COVID-19 drug, remdesivir, may disappoint

Sales of first big COVID-19 drug, remdesivir, may disappoint

LONDON: Investors betting on big profits from COVID-19 treatments may get an unwelcome surprise when Gilead Sciences Inc. reports quarterly results this month. Its remdesivir, the first important coronavirus treatment, has not been used as much as first ...

8 days ago

Massive WHO remdesivir study suggests no Covid-19 benefit. Doctors aren't so sure.

Massive WHO remdesivir study suggests no Covid-19 benefit. Doctors aren't so sure.

Remdesivir for Covid-19? A World Health Organization study shows remdesivir might not be beneficial in the sickest patients. But does remdesivir work?

8 days ago

Study says popular COVID drug remdesivir is not effective. Bay Area scientists disagree

Study says popular COVID drug remdesivir is not effective. Bay Area scientists disagree

A World Health Organization study found that a drug made by Gilead Sciences, the Foster City bitoech firm, and widely used in the Bay Area to treat coronavirus patients has “little or no effect on mortality” and may not speed up recovery. But Bay Area experts ...

8 days ago

Remdesivir doesn't reduce COVID-19 deaths, a large WHO trial finds

Remdesivir doesn't reduce COVID-19 deaths, a large WHO trial finds

Remdesivir, an antiviral drug that was the first found to combat COVID-19, doesn't reduce deaths from the disease, a large international study found. The World Health Organization's Solidarity trial, which combined data from 405 hospitals in 30 countries, ...

8 days ago

WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients

WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients

The findings add to debate over the utility of the medicine developed by Gilead Sciences in treating the new coronavirus.

8 days ago

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits. In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday ...

8 days ago

Large study led by the World Health Organization finds antiviral drug remdesivir didn't help COVID-19 patients

Large study led by the World Health Organization finds antiviral drug remdesivir didn't help COVID-19 patients

GENEVA — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many ...

8 days ago

Scientists defend trial questioning remdesivir's COVID benefits

Scientists defend trial questioning remdesivir's COVID benefits

Scientists defended a World Health Organization trial showing that the antiviral treatment remdesivir doesn't save the lives of COVID-19 patients after drugmaker Gilead Sciences Inc. criticized the findings. Remdesivir, which U.S. President Donald Trump ...

8 days ago

Remdesivir has 'no meaningful impact' on COVID-19 survival, huge study finds

Remdesivir has 'no meaningful impact' on COVID-19 survival, huge study finds

Remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results of a large, international trial.

8 days ago

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial

An antiviral widely used to treat hospitalized patients did not lower the mortality rate in a multinational trial.

8 days ago

WHO Questions Effectiveness of Remdesivir on Covid-19 Death Rates

WHO Questions Effectiveness of Remdesivir on Covid-19 Death Rates

Here's what you need to know about the impact of Covid-19 to navigate the markets today.

8 days ago

WHO study finds remdesivir didn't help COVID-19 patients

WHO study finds remdesivir didn't help COVID-19 patients

A large study led by the WHO suggests that the costly antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine...

8 days ago

Gloomy COVID drug data shows why big, randomised trials matter

Gloomy COVID drug data shows why big, randomised trials matter

LONDON (Reuters) - When it comes to trials of any drug, size matters, potentially giving the World Health Organization's (WHO) gloomy verdict on Gilead Sciences' COVID-19 treatment remdesivir an edge over the company's more positive data, leading ...

8 days ago

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19.

8 days ago

Remdesivir has 'little or no effect' in preventing COVID-19 deaths, WHO study finds

Remdesivir has 'little or no effect' in preventing COVID-19 deaths, WHO study finds

The World Health Organization announced long-awaited results of its six-month trial to see if 4 existing drugs might have an effect on the coronavirus.

8 days ago

WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 October 2020

WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 October 2020

Interim results from the Solidarity Therapeutics Trial now show that the other two drugs in the trial, remdesivir and interferon, have little or no effect in preventing death from COVID-19 or reducing time in hospital. For the moment, the corticosteroid ...

8 days ago

Gloomy COVID Drug Data Shows Why Big, Randomised Trials Matter

Gloomy COVID Drug Data Shows Why Big, Randomised Trials Matter

LONDON (Reuters) - When it comes to trials of any drug, size matters, potentially giving the World Health Organization's (WHO) gloomy verdict on Gilead Sciences' COVID-19 treatment remdesivir an edge over the company's more positive data, leading ...

8 days ago

The US is approaching 8 million Covid-19 cases, and the pace of new infections signals a tough winter

The US is approaching 8 million Covid-19 cases, and the pace of new infections signals a tough winter

Daily coronavirus infection rates are climbing in the US as the nation nears 8 million official Covid-19 cases -- a sign the country is in for a tough winter, experts say.

8 days ago

Remdesivir has little effect on COVID-19 mortality, WHO study says

Remdesivir has little effect on COVID-19 mortality, WHO study says

The antiviral drug was granted emergency use authorization earlier this year to treat COVID-19 patients.

8 days ago

WHO study finds remdesivir didn't help COVID-19 patients

WHO study finds remdesivir didn't help COVID-19 patients

GENEVA (AP) — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and ...

8 days ago

EU urged to review remdesivir supply deal after COVID trial results

EU urged to review remdesivir supply deal after COVID trial results

The European Union should renegotiate a 1 billion euro ($1.17 billion) contract it sealed last week with Gilead for a six-month supply of the COVID-19 drug remdesivir after it showed poor results in a large trial, experts said on Friday. In a blow to one of the few ...

8 days ago

Remdesivir Has 'Little or No Effect' in Reducing COVID Deaths

Remdesivir Has 'Little or No Effect' in Reducing COVID Deaths

The WHO found that remdesivir — a drug administered to President Trump during his COVID treatment — had “little or no effect” on patient survival rates.

8 days ago

Study finds Remdesivir, hydroxychloroquine and 2 other drugs have little to no effect on COVID-19

Study finds Remdesivir, hydroxychloroquine and 2 other drugs have little to no effect on COVID-19

GENEVA — The world's largest randomized trial of COVID-19 treatments found “conclusive evidence” that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has little or no effect on severe cases, the U.N. health agency said Friday.

8 days ago

WHO Study Finds Remdesivir Didn't Help COVID-19 Patients

WHO Study Finds Remdesivir Didn't Help COVID-19 Patients

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients.

8 days ago

Four repurposed drugs have little to no effect on Covid, says WHO

Four repurposed drugs have little to no effect on Covid, says WHO

India News: NEW DELHI: The multi-country solidarity trial led by the World Health Organization (WHO) has concluded that none of the four repurposed drugs that it .

8 days ago

Study Finds Remdesivir, Other Drugs Have Little to No Effect on COVID-19

Study Finds Remdesivir, Other Drugs Have Little to No Effect on COVID-19

The study, which was not peer-reviewed, found that four treatments tested — including remdesivir and hydroxychloroquine — had “ little or no effect" on whether or not patients died within about a month or whether hospitalized patients recovered.

8 days ago

Remdesivir has very little effect on Covid-19 mortality, WHO finds

Remdesivir has very little effect on Covid-19 mortality, WHO finds

Results of major trial described as sobering, with drug found not to improve survival rates.

8 days ago

BREAKING NEWS: Remdesivir has 'little effect' on COVID-19 death risks, WHO study study finds

BREAKING NEWS: Remdesivir has 'little effect' on COVID-19 death risks, WHO study study finds

The WHO's 11266-person trial found no significant reduction in mortality risks among hospitalized COVID-19 patients treated with remdesivir, lopinavir, interferon or hydroxychloroquine.

9 days ago

Remdesivir has little effect on coronavirus mortality rate: WHO

Remdesivir has little effect on coronavirus mortality rate: WHO

Remdesivir has been found to have little impact on a coronavirus patient's chances of survival, according to the World Health Organization (WHO). WHO has been conducting a trial which studies the effects of the drug, which was used to treat President ...

9 days ago

Remdesivir has little effect on mortality according to WHO study - FT

Gilead's COVID-19 treatment Remdesivir had "no substantial effect" on the survival of hospitalized patients, a WHO study seen by the FT found. But the not-

9 days ago

Remdesivir has little effect on Covid-19 mortality, WHO study says

Remdesivir has little effect on Covid-19 mortality, WHO study says

Results of highly anticipated Solidarity trial strike a blow to hopes for coronavirus treatments.

9 days ago

Realtime Search Trends

  • Top stories
  • Sports
  • Entertainment
  • Business
  • Sci/Tech